Pharmacokinetics, safety and efficacy study in pregnancy and existing cumulative data/evidence to support clinical use and labelling of bictegravir/ emtricitabine/tenofovir alafenamide (B/F/TAF) in pregnant women with HIV

被引：0
|
作者：
Marathe, Dhananjay [1 ]
Arora, Priyanka [1 ]
Zhang, Haeyoung [1 ]
Hindman, Jason [1 ]
Liu, Hui [1 ]
Girish, Sandhya [1 ]
Davis, Casey [1 ]
Palaparthy, Ramesh [1 ]
机构：
[1] Gilead Sci Inc, Foster City, CA USA
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2024年 / 90卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
26
引用
收藏
页码：19 / 19
页数：1
相关论文
共 38 条
  • [1] Pharmacokinetics, safety and efficacy of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in virologically suppressed pregnant women with HIV
    Zhang, H.
    Martin, H.
    Lin, L.
    Davis, M.
    Huang, H.
    Xiao, D.
    Arora, P.
    Avihingsanon, A.
    Koenig, E.
    Palaparthy, R.
    Girish, S.
    Marathe, D.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2023, 26
  • [2] A study of the pharmacokinetics, safety, and efficacy of bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed pregnant women with HIV
    Zhang, Haeyoung
    Hindman, Jason T.
    Lin, Ludwig
    Davis, Maggie
    Shang, Justin
    Xiao, Deqing
    Avihingsanon, Anchalee
    Arora, Priyanka
    Palaparthy, Ramesh
    Girish, Sandhya
    Marathe, Dhananjay D.
    AIDS, 2024, 38 (01) : F1 - F9
  • [3] Bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) shows high efficacy in clinical study participants infected with HIV-1 subtype F
    Acosta, R.
    Andreatta, K.
    D'Antoni, M.
    Collins, S.
    Martin, H.
    White, K.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2020, 23 : 106 - 106
  • [4] Efficacy and safety of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in combination with boosted darunavir (DRV) in treatment experienced patients with HIV
    Hill, L.
    Momper, J.
    Abulhosn, K.
    Ballard, C.
    Young, M.
    HIV MEDICINE, 2019, 20 : 81 - 81
  • [5] Longer-term (96-week) efficacy and safety of switching to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in women
    Kityo, C.
    Hagins, D.
    Koenig, E.
    Avihingsanon, A.
    Chetchotisakd, P.
    Supparatpinyo, K.
    Gankina, N.
    Pokrovsky, V.
    Voronin, E.
    Stephens, J. L.
    DeJesus, E.
    Wang, H.
    Acosta, R.
    Brainard, D.
    Martin, H.
    Makadzange, T. A.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2019, 22 : 4 - 4
  • [6] Long-term efficacy and safety of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in ART-naive adults
    Orkin, C.
    Sax, P.
    Arribas, J.
    Gupta, S.
    Martorell, C.
    Stephens, J.
    Stellbrink, H-J
    DeJesus, E.
    Maggiolo, F.
    Huang, H.
    Acosta, R.
    Brainard, D.
    Collins, S.
    Martin, H.
    HIV MEDICINE, 2020, 21 : 18 - 18
  • [7] Long-term efficacy and safety of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in ART-naive adults
    Orkin, C.
    Sax, P. E.
    Arribas, J.
    Gupta, S.
    Martorell, C.
    Stephens, J. L.
    Stellbrink, H-J
    Dejesus, E.
    Maggiolo, F.
    Huang, H.
    Acosta, R.
    Brainard, D. M.
    Collins, S. E.
    Martin, H.
    HIV MEDICINE, 2019, 20 : 94 - 95
  • [8] Switch to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) among vulnerable HIV-infected individuals: evidence for long-term efficacy
    Truong, David
    Yi, Shana
    Wiesmann, Christina
    Conway, Brian
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 181 - 181
  • [9] Pharmacokinetics, safety, and efficacy of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) single-tablet regimen in HIV-1-infected children (6 to <12 years)
    Cotton, M.
    Liberty, A.
    Rodriguez, C. A.
    Chokephaibulkit, K.
    Kosalaraksa, P.
    Hellstrom, E.
    Natukunda, E.
    Wong, P.
    Majeed, S. R.
    Quirk, E.
    Graham, H.
    Pikora, C.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21 : 38 - 39
  • [10] High efficacy of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in Black adults in the United States, including those with pre-existing HIV resistance and suboptimal adherence
    Andreatta, Kristen
    DAntoni, Michelle L.
    Chang, Silvia
    Parvangada, Aiyappa
    Martin, Ross
    Blair, Christiana
    Hagins, Debbie
    Kumar, Princy
    Hindman, Jason T.
    Martin, Hal
    Callebaut, Christian
    JOURNAL OF MEDICAL VIROLOGY, 2024, 96 (10)
1234